Patent foramen ovale and atrial septal aneurysm in cryptogenic stroke

Sujoy Ghosh1, Arjun Kumar Ghosh, Sandip Kumar Ghosh

  • 1Ayr Hospital, Dalmellington Road, Ayr, Ayrshire, UK.

Insights

Cryptogenic strokes in young adults often involve a patent foramen ovale (PFO). While antiplatelet agents or warfarin are common treatments, PFO closure is reserved for specific cases due to inconclusive evidence on stroke prevention.

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Medicine

Background:

  • Cryptogenic strokes account for up to 40% of ischemic strokes in young adults.
  • Patent foramen ovale (PFO) is identified in over half of these patients, often with an atrial septal aneurysm.
  • Echocardiography, particularly transesophageal echocardiography, is the primary diagnostic tool.

Purpose of the Study:

  • To review the diagnostic approaches and management strategies for cryptogenic strokes in young adults.
  • To evaluate the role of patent foramen ovale (PFO) in stroke etiology and recurrence.
  • To discuss the current evidence regarding PFO closure versus medical therapy for stroke prevention.

Main Methods:

  • Literature review of studies investigating cryptogenic stroke, PFO, and atrial septal aneurysm.
  • Analysis of diagnostic methods, including echocardiography.
  • Examination of treatment outcomes for antiplatelet agents, warfarin, and percutaneous PFO closure.

Main Results:

  • Patent foramen ovale (PFO) is a frequent finding in cryptogenic strokes among young individuals.
  • Low-risk patients are typically managed with antiplatelet agents, while high-risk patients receive warfarin.
  • Data on the efficacy of PFO closure for preventing recurrent stroke remain inconclusive.

Conclusions:

  • Patent foramen ovale (PFO) is a significant consideration in the workup of cryptogenic strokes in young adults.
  • Medical therapy (antiplatelets or warfarin) is the standard initial treatment based on risk stratification.
  • Percutaneous PFO closure is considered for recurrent stroke or medical therapy intolerance, despite limited evidence of its preventative efficacy.

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
The Arch of Aorta01:10

The Arch of Aorta

The coronary arteries, originating from the ascending aorta, bifurcate from two sinuses located within the ascending aorta. Positioned just above the aortic semilunar valve, these sinuses house essential aortic baroreceptors and chemoreceptors, crucial for maintaining cardiac function. The left coronary artery and the right coronary artery branch off from the left posterior and anterior aortic sinuses, respectively.
Encircling the heart, the coronary arteries form a ring-like structure before...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...